Skip to main content
VITRAFY LIFE SCIENCES LIMITED logo

VITRAFY LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · VFY ISIN · AU0000361297 ASX Professional, scientific and technical activities
Filings indexed 100 across all filing types
Latest filing 2026-06-19 Capital/Financing Update
Country AU Australia
Listing ASX VFY

About VITRAFY LIFE SCIENCES LIMITED

https://www.vitrafy.com

Vitrafy Life Sciences Limited specializes in the development and commercialization of advanced cryopreservation technologies designed to optimize the preservation and transport of biological materials. The company provides end-to-end cold chain solutions, focusing on maintaining the viability and functionality of sensitive life science products, including cells, tissues, and organs. Its core technology utilizes precise, automated cooling and warming protocols to minimize cellular damage during the freezing process, addressing critical challenges in regenerative medicine, cell and gene therapy, and biobanking. By integrating hardware, software, and specialized consumables, Vitrafy aims to standardize cryopreservation workflows and improve clinical outcomes through enhanced sample recovery and data-driven monitoring throughout the supply chain.

Recent filings

Filing Released Lang Actions
Vitrafy Share Purchase Plan Opens - SPP Offer Booklet 24 pages 1.6MB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 19 June 2026 from Vitrafy Life Sciences Limited regarding the opening of a Share Purchase Plan (SPP). It details the offer to shareholders about purchasing new shares, the record date, the pricing, and terms of the SPP. It includes a booklet addressed to shareholders explaining the terms, key dates, eligibility, and instructions on how to participate in the capital raising. There is no financial performance data, financial statements, management discussion, or regulatory certifications. The primary content is about raising capital through issuing new shares. This matches the description for a Capital/Financing Update (CAP) filing, as it relates to company fundraising and capital structure changes through an SPP. The document length and detail exceed what would typically be a brief announcement; it is not an initial earnings release, regulatory filing, or a report publication announcement.
2026-06-19 English
Application for quotation of securities - VFY 6 pages 18.6KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A Form titled 'Application for quotation of securities' for VITRAFY LIFE SCIENCES LIMITED, dated June 18, 2026. It discusses details about the quotation of new securities on ASX, references prior Appendix 3B announcements related to securities issuance, placement details, issued capital after quotation, and associated share classes. There is no indication of financial results, earnings, management commentary, or regulatory certifications; rather, this document serves as a formal announcement to register newly issued shares for quotation on the stock exchange. Appendix 2A is specifically an application for quotation of shares post-issuance, which aligns with announcements relating to capital or financing activities rather than the issuance itself. This fits the category of Capital/Financing Update (CAP) which covers updates on company fundraising, financing activities, or capital structure changes.
2026-06-18 English
Cleansing Notice 2 pages 213.4KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement dated 18 June 2026 concerning the issuance of 11,538,462 new shares under a placement at a specified price. It references compliance with the Corporations Act relating to disclosure requirements and serves as a cleansing notice for a share purchase plan. This type of announcement details issuances of new shares and related regulatory compliance but does not contain financial statements, management analysis, or overall financial results. The document is concise and fits the profile of a share issuance announcement rather than a full financing update or capital report. Therefore, it best fits the category of Share Issue/Capital Change announcements (SHA). The document length (2940 characters) and content further support it being an announcement rather than a full report or detailed data.
2026-06-18 English
Vitrafy Equity Raising Presentation 39 pages 1.6MB
Investor Presentation Classification · 92% confidence The document is an equity‐raising slide deck prepared by Vitrafy Life Sciences for institutional placement and share purchase plan, including detailed business overview, strategy, financial summary, and disclaimers typical of an investor pitch. It is not a regulatory report, earnings release, or formal prospectus, but a presentation aimed at investors for financing purposes. Therefore, it is classified as an Investor Presentation.
2026-06-12 English
Proposed issue of securities - VFY 9 pages 28.0KB
Share Issue/Capital Change Classification · 85% confidence The document is an Australian Securities Exchange (ASX) Listing Rule Appendix 3B that outlines a proposed issue of securities, detailing a securities purchase plan and a placement. It provides the number of shares, prices, timetable, conditions, approval status, and related listing rule information. This is a direct announcement of new share issues and capital changes, matching the definition of Share Issue/Capital Change.
2026-06-12 English
Vitrafy Placement Completion and SPP Announcement 3 pages 269.2KB
Capital/Financing Update Classification · 93% confidence The document is an ASX announcement detailing an institutional placement to raise A$30 million, including share issue details, discounts to VWAP, and a concurrent Share Purchase Plan. It is clearly a fundraising/financing update rather than a full report or other corporate action. Therefore, it falls under Capital/Financing Update (CAP).
2026-06-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.